𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma

✍ Scribed by MS Piver; SB Lele; B Patsner; LJ Emrich

Book ID
118888305
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
136 KB
Volume
25
Category
Article
ISSN
0020-7292

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparison of 5-fluorouracil with 5-fluo
Comparison of 5-fluorouracil with 5-fluorouracil, cyclophosphamide, and methotrexate in metastatic colorectal carcinoma
✍ Frederick Richards II; Thomas L. Pajak; Miles R. Cooper; Charles L. Spurr πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 1 views

Thirty-eight patients with metastatic colorecal carcinoma were treated with 5-fluorouracil (5-FU), and 38 patients were treated with the combination of 5-FU, cyclophosphamide, and methotrexate. In terms of percent response, response duration, and survival there was no apparent difference between the

Medroxyprogesterone acetate (depo-prover
Medroxyprogesterone acetate (depo-provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma
✍ M. Steven Piver; Joseph J. Barlow; John R. Lurain; Leslie E. Blumenson πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 430 KB

A prospective trial was initiated in 1972 utilizing Depo-Provera in women with metastatic or recurrent endometrial adenocarcinoma to evaluate if the objective response and survival would be significantly improved in comparison to patients previously treated with Delalutin at a similar dose. One hund